Alzheimer's disease (AD) is the most common form of dementia, characterized by
progressive cognitive impairment and neurodegeneration. Extensive clinical and genomic …

Biological research has undergone tremendous changes over the past three decades.
Research used to almost exclusively focus on a single aspect of a single molecule per …

Background and Purpose Alzheimer's disease (AD) is a devastating neurodegenerative
disorder with no cure, and available treatments are only able to postpone the progression of …

Objective We develop a deep learning framework based on the pre-trained Bidirectional
Encoder Representations from Transformers (BERT) model using unstructured clinical notes …

Background For the recruitment and monitoring of subjects for therapy studies, it is important
to predict whether mild cognitive impaired (MCI) subjects will prospectively develop …

Background The increasing prevalence of neurocognitive disorders (NCDs) in the aging
population worldwide has become a significant concern due to subjectivity of evaluations …

Alzheimer's disease (AD) is a progressive neurodegenerative disease with phenotypic
changes closely associated with both genetic variants and imaging pathology. Brain …

Neurodegenerative diseases such as Alzheimer's disease (AD) are characterized by the
progressive loss of neurons in the brain and the spinal cord. The pathophysiology of AD is …

Alzheimer's disease (AD) is a progressive neurological disease that worsens with time. The
hallmark illnesses include extracellular senile plaques caused by β-amyloid protein …

Beyond the core features of Alzheimer's disease (AD) pathology, ie amyloid pathology, tau-
related neurodegeneration and microglia response, multiple other molecular alterations and …